Inventurus Knowledge Solutions Limited (NSE:IKS)
India
· Delayed Price · Currency is INR 1,653.90
+6.70 (0.41%)
May 15, 2025, 3:30 PM IST
NSE:IKS Revenue
In the fiscal year ending March 31, 2025, Inventurus Knowledge Solutions had annual revenue of 27.03B INR with 48.69% growth. Inventurus Knowledge Solutions had revenue of 7.27B in the quarter ending March 31, 2025, with 14.60% growth.
Revenue
27.03B
Revenue Growth
+48.69%
P/S Ratio
11.09
Revenue / Employee
1.99M
Employees
12,862
Market Cap
283.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27.03B | 8.85B | 48.69% |
| Mar 31, 2024 | 18.18B | 7.87B | 76.28% |
| Mar 31, 2023 | 10.31B | 2.68B | 35.05% |
| Mar 31, 2022 | 7.64B | 2.11B | 38.20% |
| Mar 31, 2021 | 5.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 271.45B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |